- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Dr Reddys unveils generic Fulvestrant injection for breast cancer in US
Faslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
New Delhi: Pharma major Dr. Reddy''s Laboratories on Monday said it has launched a generic Fulvestrant injection, used for the treatment of advanced breast cancer, in the US market.
The company has launched Fulvestrant injection, 250 mg/5 mL (50 mg/mL) per single-dose syringe, approved by the United States Food and Drug Administration (USFDA), Dr Reddy''s Laboratories said in a filing to BSE.
The product is a generic version of Faslodex injection in the same strength, it added.
According to the IQVIA Health data, Faslodex brand and generic market had US sales of around USD 407 million MAT for 12 months to June 2020, the filing said.
Read also: Dr Reddys launches generic version of Cuprimine Capsules in US
Faslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
Shares of Dr. Reddy''s Laboratories closed at Rs 4,422.25 on BSE, up 2.29 percent from the previous close.
Read also: Dr. Reddys unveils Methylphenidate Hydrochloride ER Tablets in US
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751